Source: Annual Congress 2007 - Novel mediators of cellular pathology
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
J. Floros, Z. Lin, N. Thomas, M. Bibikova, C. Seifart, Y. Wang, X. Guo, G. Wang, E. Vollmer, T. Goldmann, E. W. Garcia, L. Zhou, J. B. Fan (Hershey, PA, San Diego, CA, United States Of America; Marburg, Borstel, Germany). DNA methylation markers of surfactant proteins in lung cancer. Eur Respir J 2007; 30: Suppl. 51, 3069

Member's Comments

No comment yet.

Related content which might interest you: DNA methylation marker for NSCLC and adjacent normal lung tissue using NotI-MseI methylation chip Source: Eur Respir J 2007; 30: Suppl. 51, 132s Year: 2007 DNA methylation and histone modifications of susceptibility in COPD and lung cancer Source: Annual Congress 2011 - Why is epigenetics important for lung disease? Year: 2011 DNA methylation is associated with lung function levels in never-smokers Source: International Congress 2017 – Epigenetics of lung function Year: 2017 Hypermethylation pattern in genomic DNA samples derived from tumor and serum of resected non-small cell lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 674s Year: 2004 DNA methylation and lung function: an epigenome-wide association study Source: International Congress 2017 – Epigenetics of lung function Year: 2017 Profile of WT1 methylation in human lung cancer Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 DNA damage in lymphocytes from COPD patients with and without lung cancer Source: International Congress 2017 – Latest insights into the management of chronic lung diseases Year: 2017 Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathological characteristics of primary non small cell lung carcinoma Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 DNA methylation profiling of non-small cell lung cancer reveals an immune signature in COPD patients Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013 Circulating free DNA, new dynamic marker in nonsmall cell lung cancer patients? Source: Eur Respir J 2015; 46: 1548-1550 Year: 2015 Polymorphism in GSTM1, GSTT1, p53 and CCR5 genes and lung cancer progression: relation to p53 and Ki-67 protein expression in tumors of non-small cell lung cancer patients Source: Eur Respir J 2006; 28: Suppl. 50, 810s Year: 2006 p16INK4a promoter hypermethylation in tissue, blood, and sputum from non-small cell lung cancer and pulmonary inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 813s Year: 2006 Aberrant promoter methylation in sputum and bronchial washing in patients at risk for lung cancer Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer Year: 2009 Epithelial cell matrix proteins and lymphocyte activation genes in COPD and lung cancer Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009 Recognition of aberrant promoter methylation for early diagnosis of lung cancer patients Source: Virtual Congress 2020 – Screening and early lung cancer Year: 2020 Loss of heterozygosity detected in plasma DNA of early stage lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 673s Year: 2004 Cellular matrix and proliferation proteins in COPD and lung cancer Source: Annual Congress 2008 - Airway infection and host defence Year: 2008 Quantitative methylation profiles of multiple genes in patients with non-small cell lung cancer and its association with clinicopathological correlations Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011 Evaluation of promoter hypermethylation in tissue and blood of non-small cell lung cancer patients and association with survival. Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018